Orexigen Therapeutics Sees Shares Slide Pre-Market; Eli Lily Edges Up
Shares of Orexigen Therapeutics (NASDAQ:OREX) slipped in Tuesday’s pre-market session, after the developer of drug treatments for obesity and related disorders said it received a Day 120 List of Questions regarding the marketing authorization application for its NB32 weight-loss drug candidate from the European Medicines Agency’s Committee for Medicinal Products for Human Use. The company said the EMA reviewers’ questions “are consistent with issues raised … Continue reading Orexigen Therapeutics Sees Shares Slide Pre-Market; Eli Lily Edges Up